Table 1.
Characteristics | Higher eGFR at Dialysis Initiation (n=4327) | Lower eGFR at Dialysis Initiation (n=10,843) | P Value |
---|---|---|---|
eGFR (ml/min per 1.73 m2), median (IQR) | 12.8 (11.1–16.0) | 6.5 (4.8–8.0) | <0.001 |
Median age in years (IQR) | 14 (9–16) | 14 (10–17) | <0.001 |
Age category, N (%) | <0.001 | ||
Age 1 to <5 yr | 572 (13.2) | 928 (8.6) | |
Age 5 to <13 yr | 1261 (29.1) | 2937 (27.1) | |
Age ≥13 yr | 2494 (57.6) | 6978 (64.4) | |
Girls, N (%) | 2173 (50.2) | 4850 (44.7) | <0.001 |
Race/ethnicity, N (%) | <0.001 | ||
Non-Hispanic white | 1945 (45.0) | 4082 (37.6) | |
Non-Hispanic black | 1023 (23.6) | 3046 (28.1) | |
Hispanic | 1107 (25.6) | 3108 (28.7) | |
Asian | 164 (3.8) | 437 (4.0) | |
Other/unknown | 88 (2.0) | 170 (1.6) | |
Primary cause of ESRD, N (%) | <0.001 | ||
GN | 2012 (46.5) | 4484 (41.3) | |
CAKUT | 1219 (28.2) | 3232 (29.8) | |
Diabetes | 26 (0.6) | 71 (0.7) | |
Hypertension | 121 (2.8) | 526 (4.8) | |
Malignancy | 59 (1.3) | 71 (0.7) | |
Other or unknown | 890 (20.6) | 2459 (22.7) | |
BMI category by z-score, N (%) | 0.01 | ||
<5th% (underweight) | 542 (12.5) | 1231 (11.4) | |
5th%–94th% (normal weight) | 2757 (63.7) | 7180 (66.2) | |
≥95th% (obese) | 1028 (23.8) | 2432 (22.4) | |
Mean serum albumin (g/dl), (SD)a | 3.2 (1.1) | 3.3 (1.3) | <0.001 |
Median hemoglobin (g/dl), (IQR)b | 9.9 (8.6, 11.2) | 9.1 (7.7, 10.6) | <0.001 |
Comorbidity, N (%) | |||
Hypertensionc | 2002 (47.0) | 4763 (44.7) | 0.01 |
Cardiovascular diseased | 279 (6.5) | 504 (4.7) | <0.001 |
Other comorbiditiese | 339 (7.8) | 492 (4.5) | <0.001 |
Distance between patient and dialysis center (miles), median (IQR) | 15.1 (6.3, 45.0) | 14.1 (5.8, 41.0) | <0.001 |
Insurance, % (N) | |||
Medicaid | 2369 (54.8) | 5305 (48.9) | <0.001 |
None | 147 (3.4) | 999 (9.2) | <0.001 |
PD modality, N (%)f | 1805 (42.2) | 4179 (39.2) | 0.001 |
CAKUT, congenital anomalies of the kidney and urinary tract.
Missing in n=2231.
Missing in n=1019.
Missing in n=266.
Cardiovascular disease includes stroke, heart failure, coronary artery disease, peripheral vascular disease, and other cardiac disease.
Other comorbidities include cancer, diabetes, immobility, tobacco, alcohol or drug use, and chronic obstructive pulmonary disease.
Missing in n=239.